Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle.
The cytokine cachectin/TNF induces a rapid increase in lactate production and in glucose metabolism in L6 myocytes in culture; glucose uptake was maximal after 17 h, while elevated glucose utilization and lactate production persisted for up to 32 h. These increases are suggestive of increased glycolytic activity, and were associated with a 10% decrease in cellular oxygen consumption and a comparable decrease in the production of 14C-labelled CO2 from 14C-labelled glucose. This decrease in aerobic metabolism, however, could account for only a small fraction of the energetic requirement for increased glycolytic activity. Furthermore, maximal stimulation of pyruvate dehydrogenase (PDH) by dichloroacetate (DCA) treatment in conjunction with cachectin/TNF abolished lactate production, but increased glucose uptake persisted. Taken together, this suggests that the primary effect of cachectin/TNF on myocyte carbohydrate metabolism is to increase glycolysis. Correspondingly, we postulated that cachectin/TNF must activate one or more ATP-depleting cellular processes to account for the lack of feed-back inhibition on glycolysis by the ATP produced. This led to the identification of a futile substrate cycle between fructose 6-phosphate and fructose 1,6-bisphosphate as a novel energy sink that is activated by cachectin/TNF. Cachectin/TNF treatment led to increased activity of both phosphofructokinase (PFK) and fructose bisphosphate phosphatase (FBP) in myocytes in culture, detectable after 1 h of incubation and persisting for up to 16 h. The possible role of cachectin/TNF-mediated futile substrate cycling in increased glycolytic activity, increased energy expenditure, heat production and tissue wasting during bacterial infections is discussed.
Zentella
A
A
Program of Cell Biology and Genetics, Memorial Sloan Kettering Cancer Center, NY.
Manogue
K
K
Cerami
A
A
D000818:Animals; D002478:Cells, Cultured; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D007773:Lactates / Q000096:biosynthesis*; D019344:Lactic Acid; D009132:Muscles / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D007773:Lactates; D014409:Tumor Necrosis Factor-alpha; D019344:Lactic Acid; D005947:Glucose